Moderator: Jane Montealegre, Ph.D., Deputy Director, Office of Outreach and Health Disparities, Dan L. Session II: Advances and Gaps in Risk Assessment and Prevention Moderator: Amit Singal, M.D., Medical Director, Liver Tumor Program and Clinical Chief of Hepatology, UT Southwestern Medical Center Welcome and OverviewĬhair and Professor, Department of Medicine, Baylor College of Medicine Liver Cirrhosis and Cancer 101: Disease Burden, Risk Factors and DisparitiesĪssociate Professor, Department of Medicine, Baylor College of Medicine Session I: Overview of the Liver Cancer Epidemic in Texas Learn more here or text BAKER to 243725 to give today. Please consider supporting our work by making a gift or joining a membership group.
This event was co-sponsored by the Baker Institute Center for Health and Biosciences and t he Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine (funded by the Cancer Prevention and Research Institute of Texas).įollow on Twitter, and join the conversation online with #BakerHealth.Įvents and webinars are powered by the contributions of our donors and members. Stakeholders across the care continuum considered how best to bridge the gaps in prevention and treatment of HCC in Texas, with a focus on driving advocacy efforts for policies aimed at statewide elimination of liver cancer/HCC and hepatitis. With one of the highest rates of end-stage liver disease and liver cancer in the country, Texas is uniquely impacted by this issue. Veterans Affairs leadership and professional societies also convened to discuss HCC in Texas and how they might guide strategies to improve HCC prevention, screening, diagnosis and treatment. This year's symposium combined presentations on current HCC research with a multi-stakeholder conference that brought together elected officials and decision-makers, community groups and industry representatives.
John Ward, director of the Task Force for Global Health’s Coalition for Global Hepatitis Elimination, who discussed how to move from science to policy to eliminate hepatocellular carcinoma (HCC), the most common type of primary liver cancer. The event featured a keynote address by Dr. The Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine hosted its third annual symposium on September 17, 2022, under the leadership of Dr.
0 kommentar(er)
